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Introduction
Protein aggregation is a major concern during monoclonal
antibody (mAb) production [1,2]. The presence of aggre-
gates can reduce the therapeutic efficacy of mAbs and trig-
ger immunogenic responses upon administration [3].
Higher molecular weight (HMW) aggregates can be
removed during downstream processing (DSP), but pre-
vention of aggregate formation upstream could increase
process yield [4,5]. Unfortunately, detection of aggregates
upstream is challenging, since the size of aggregates ranges
from small oligomers to visible particles and there is no
single technique capable of measuring the broad range of
aggregation phenomena [6,7]. For upstream detection of
aggregates, all HMW species potentially present in the cul-
ture broth must be known. Therefore, we established
methods to generate different types of aggregates and
characterized the different HMW species using size exclu-
sion high pressure liquid chromatography (SE-HPLC),
dynamic light scattering (DLS) and UV spectroscopy.
Furthermore, stability and traceability of the aggregates in
cell culture medium and Chinese hamster ovary (CHO)
DG44 supernatant were demonstrated. Finally, the estab-
lished methods were used to monitor aggregate formation
in a mAb producing CHO DG44 cell culture.
Material and methods
Two mAbs produced in CHO DG44 cells and stored in
20 mM acetate at pH 3.5 were used for aggregation stu-
dies. Aggregation was induced using heat stress, pH-shift,
high salt concentration and freeze-thawing. Heat stress
was induced at 65 °C for different time periods. For the
pH-shift, the antibody was diluted in citrate-phosphate
buffer containing pH 3-8. NaCl concentrations for
salt-induced aggregation varied from 50-1500 mM.
A freeze-thawing cycle included incubation at -80 °C for
15 min followed by thawing at 25 °C for 15 min. The
freeze-thaw cycle was repeated three times. The presence
of small aggregates was evaluated using SE-HPLC
equipped with a Yarra SEC4000 (Phenomenex) column.
To identify the different HMW species the molecular
weight was determined using SEC-MALS (multi-angle
light scattering). Moreover, large aggregates were
characterized using DLS (Zetasizer 3000HS, Malvern
instruments) and UV spectroscopy (SpectraMax M5e
microplate reader, Molecular Devices). The size of large
aggregates was displayed by the average diameter. The
aggregation index (AI) was calculated from UV absor-
bance using the following equation: A340×100/(A280-
A340). Furthermore, stability of induced aggregates in cell
culture medium (SFM4CHO, Thermo Scientific) and
CHO DG44 host cell supernatant was investigated.
Therefore, freeze-thawed mAb2 was spiked into the cul-
ture medium as well as CHO DG44 host cell supernatant
and analyzed via SE-HPLC. Finally, the supernatant of
CHO DG44 mAb2 producer cells was analyzed directly
after inoculation and at the end of cultivation. Based on
results obtained from spiking aggregated mAb2 into
CHO DG44 host cell supernatant, aggregate formation in
a culture of a mAb producing CHO DG44 cell line was
monitored.
Results
All stress methods provoked aggregate formation. The
mAbs showed formation of different aggregates using
the different stress methods (Table 1). Heating the anti-
body only led to formation of large aggregates. Despite
the loss of mAb2 monomer, no small aggregates were
detected via SE-HPLC. However, heat induction pro-
voked formation of large aggregates, whereby the aver-
age size (diameter > 1 μm) and AI increased over time
at 65 °C. Hence, heat induction can only be used to
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generate large aggregates of the mAbs used in this
study. The pH change provoked formation of small
aggregates (dimer and oligomer) as well as large aggre-
gates (diameter > 75 nm). With increasing pH dimer
and oligomer levels also increased, whereas an increased
diameter was only observed for pH 5 and 6. Thus, a
shift to pH 6 can be used for induction of dimers, oligo-
mers and large aggregates. The addition of NaCl pro-
voked concentration-dependent formation of dimers and
large aggregates (diameter > 50 nm) at higher NaCl con-
centrations (above 500 mM). In contrast to pH-induc-
tion, no oligomers larger than dimer were visible via SE-
HPLC. Therefore, NaCl can be used for the fast genera-
tion of dimers and above a concentration of 500 mM
for the induction of large aggregates. With increasing
freeze thaw cycles formation of small aggregates
occurred. Surprisingly, more aggregates were formed
than with all other methods. Hence, freeze-thawing was
used to study the stability of aggregates under culture
conditions.
For this purpose, freeze-thawed mAb2 was spiked into
culture medium and analyzed using SE-HPLC (Figure 1,
A). Since the retention time of cell culture medium com-
ponents differed from the freeze-thawed antibody, mono-
mer and the aggregates were still detectable. Accordingly,
freeze-thawing was preferred for the use in cell culture
supernatant spiking experiments. The investigation of
freeze-thawed (3x) mAb2 spiked into CHO DG44 host
cell supernatant revealed that mAb2 monomers as well
as the aggregates (22% dimer and 72% oligomer) were
still detectable and quantifiable via SE-HPLC. Knowing
the retention time of different aggregate species, the ana-
lysis of the supernatant of a CHO DG44 mAb producing
cell line was performed at the beginning and after 144 h
cultivation (Figure 1, B). Aggregates and monomer could
successfully be detected after 144 h via SE-HPLC,
whereas after inoculation neither monomer nor aggre-
gates were visible. Therefore, the methods established in
this work can be used to generate different types of
aggregates as positive control to evaluate aggregate for-
mation in cell culture supernatant.
Summary
The stress methods used in this work induced different
types of aggregates. Heating the antibody led to a loss of
monomer and only formation of large aggregates.
Dimers and oligomers were formed with increasing pH
and large aggregates were formed at pH 5 and 6. A
NaCl concentration dependent aggregate formation was
observed, whereby only dimers were visible via SE-
HPLC and large aggregates were only present at a NaCl
concentration above 500 mM. Freeze-thawing induced
more aggregates as with all other methods and was
therefore used for the application under cell culture
conditions. Spiking experiments of freeze-thawed mAb2
in culture medium and CHO DG44 host cell superna-
tant revealed that aggregates were still detectable and
quantifiable under cell culture conditions. Finally, this
work showed that aggregate formation directly in the
supernatant of a CHO DG44 mAb producing cell line is
possible.
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Table 1 Formation of different HMW species using
different induction methods.
Induction Method Small aggregates Large aggregates
Dimer Oligomer
Heat - - Up to 1 μm
pH Increase with pH + At pH 5 and 6
NaCl Increase with NaCl - Above 500 mM
Freeze-thawing + + -
Figure 1 Freeze-thawed mAb2 spiked into cell culture medium (A) and supernatant of CHO DG44 mAb producer cells (B).
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